Dolutegravir 50 mg , Tenofovir disoproxil Fumarate 300 mg and Lamivudine 300 mgTablets

/

Dolutegravir 50 mg, Tenofovir Disoproxil Fumarate 300 mg, Lamivudine 300 mg Tablets

antiretroviral medications widely used in HIV management and combination therapy. Each tablet plays a distinct role in viral suppression while complementing the others for optimal therapeutic outcomes.

At Kureasia Pharma, we provide contract and third-party manufacturing of Dolutegravir 50 mg, Tenofovir Disoproxil Fumarate 300 mg, Lamivudine 300 mg Tablets, ensuring WHO-GMP certified quality, bulk production, and customized packaging.

 

Dolutegravir 50 mg, Tenofovir Disoproxil Fumarate 300 mg, Lamivudine 300 mg Tablets – Overview and Benefits

Dolutegravir 50 mg, Tenofovir Disoproxil Fumarate 300 mg, Lamivudine 300 mg Tablets are used individually or in combination for effective HIV treatment.

Key Benefits:

  • Once-daily dosing for patient convenience

  • High bioavailability and efficacy

  • WHO-GMP certified production for consistent quality

  • Suitable for contract and third-party bulk manufacturing

 

 

Tablet NameStrengthDosage FormCertificationManufacturing TypePackaging OptionsQuality Assurance
Dolutegravir 50 mg, Tenofovir Disoproxil Fumarate 300 mg, Lamivudine 300 mg Tablets50 mg, 300 mg, 300 mgTabletsWHO-GMP CertifiedContract & Third-PartyBlister Packs, Bottles, BulkMulti-level QC checks

Contract & Third-Party Manufacturing Services

Kureasia Pharma offers comprehensive manufacturing solutions for Dolutegravir 50 mg, Tenofovir Disoproxil Fumarate 300 mg, Lamivudine 300 mg Tablets:

  • Custom contract manufacturing per client requirements

  • Third-party manufacturing with branding and packaging options

  • Bulk production for domestic and international markets

  • WHO-GMP certified production ensuring quality and safety

Quality Assurance & Regulatory Compliance

Quality is paramount. Each batch of Dolutegravir 50 mg, Tenofovir Disoproxil Fumarate 300 mg, Lamivudine 300 mg Tablets undergoes:

  • Raw material testing

  • In-process monitoring

  • Final product quality analysis

All tablets are manufactured under WHO-GMP guidelines, ensuring safe, effective, and reliable antiretroviral therapy products for global distribution.

 

Why Choose Kureasia Pharma
  • WHO-GMP certified production for international compliance

  • Bulk manufacturing with flexible packaging options

  • Expertise in contract and third-party manufacturing

  • Timely delivery and regulatory support

 

Contact Us

Office Info

+91 95577 45784

+91 93110 19560

011-40234824

sales@kureasiapharma.com

B- 255,Third Floor, Munshi Ram Gupta Marg, Naraina Industrial Area Phase 1, New Delhi 110028

Industrial Area, Plot Number-1, Khasra No. 882, 883k, Village-Salempur, Mehdood-II, Haridwar 249402, INDIA

Enquire Now Button